These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3995112)

  • 21. The dexamethasone suppression test and unipolar/bipolar distinctions.
    Zisook S; Janowsky DS; Overall JE; Risch SC
    J Clin Psychiatry; 1985 Nov; 46(11):461-5. PubMed ID: 4055705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of biologic markers in a general hospital affective disorders program.
    Lieber AL; Newbury N
    J Clin Psychiatry; 1985 Jun; 46(6):217-21. PubMed ID: 3922959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive functioning in euthymic bipolar I and bipolar II patients.
    Dittmann S; Hennig-Fast K; Gerber S; Seemüller F; Riedel M; Emanuel Severus W; Langosch J; Engel RR; Möller HJ; Grunze HC
    Bipolar Disord; 2008 Dec; 10(8):877-87. PubMed ID: 19594503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The specificity of the dexamethasone suppression test in endogenous depressive patients.
    Lu RB; Ho SL; Huang HC; Lin YT
    Neuropsychopharmacology; 1988 May; 1(2):157-62. PubMed ID: 3251496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of psychiatric co-morbidity on cognitive functioning in a population-based sample of depressed young adults.
    Castaneda AE; Marttunen M; Suvisaari J; Perälä J; Saarni SI; Aalto-Setälä T; Aro H; Lönnqvist J; Tuulio-Henriksson A
    Psychol Med; 2010 Jan; 40(1):29-39. PubMed ID: 19413917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dexamethasone suppression test in borderlines: is it useful?
    Korzekwa M; Steiner M; Links P; Eppel A
    Can J Psychiatry; 1991 Feb; 36(1):26-8. PubMed ID: 2029680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility.
    Greden JF; Gardner R; King D; Grunhaus L; Carroll BJ; Kronfol Z
    Arch Gen Psychiatry; 1983 May; 40(5):493-500. PubMed ID: 6340634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The dexamethasone suppression test in affective disorders. A review].
    Charles G; Wilmotte J; Mendlewicz J
    Acta Psychiatr Belg; 1982; 82(3):349-62. PubMed ID: 6299064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial dexamethasone suppression tests in depressed patients treated only with electroconvulsive therapy.
    Grunhaus L; Zelnik T; Albala AA; Rabin D; Haskett RF; Zis AP; Greden JF
    J Affect Disord; 1987; 13(3):233-40. PubMed ID: 2960715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical polymorphism of depression and cognitive deficit].
    Bobrov AE; Kursakov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(8):19-24. PubMed ID: 25345626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone suppression test in depressive stroke patients.
    Dam H; Pedersen HE; Damkjaer M; Ahlgren P
    Acta Neurol Scand; 1991 Jul; 84(1):14-7. PubMed ID: 1927256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dexamethasone suppression test as a predictor of sleep deprivation antidepressant effect.
    King D; Dowdy S; Jack R; Gardner R; Edwards P
    Psychiatry Res; 1982 Aug; 7(1):93-9. PubMed ID: 6957903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression and dexamethasone suppression testing in children and adolescents.
    Emslie GJ; Weinberg WA; Rush AJ; Weissenburger J; Parkin-Feigenbaum L
    J Child Neurol; 1987 Jan; 2(1):31-7. PubMed ID: 3624827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep electroencephalographic measures in primary major depressive disorder: distinction between DST suppressor and nonsuppressor patients.
    Kerkhofs M; Missa JN; Mendlewicz J
    Biol Psychiatry; 1986 Feb; 21(2):228-32. PubMed ID: 3947701
    [No Abstract]   [Full Text] [Related]  

  • 37. Asymmetry of recall in depression.
    Deptula D; Manevitz A; Yozawitz A
    J Clin Exp Neuropsychol; 1991 Nov; 13(6):854-70. PubMed ID: 1779026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep EEG and DST findings in anergic bipolar depression.
    Thase ME; Himmelhoch JM; Mallinger AG; Jarrett DB; Kupfer DJ
    Am J Psychiatry; 1989 Mar; 146(3):329-33. PubMed ID: 2919689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function.
    Watson S; Thompson JM; Ritchie JC; Nicol Ferrier I; Young AH
    Bipolar Disord; 2006 Feb; 8(1):85-90. PubMed ID: 16411985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings.
    Rush AJ; Schlesser MA; Roffwarg HP; Giles DE; Orsulak PJ; Fairchild C
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):23-9. PubMed ID: 6409892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.